Literature DB >> 6091537

In vitro bactericidal synergy of gentamicin combined with penicillin G, vancomycin, or cefotaxime against group G streptococci.

K Lam, A S Bayer.   

Abstract

The in vitro bactericidal interactions of penicillin G, cefotaxime, or vancomycin in combination with gentamicin were compared against 20 group G streptococci by the timed kill curve method. Synergy was noted at the following frequencies: penicillin plus gentamicin, 80%; cefotaxime plus gentamicin, 85%; vancomycin plus gentamicin, 90%. There was no bactericidal antagonism observed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6091537      PMCID: PMC284132          DOI: 10.1128/AAC.26.2.260

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Group G streptococcal endocarditis.

Authors:  E Bouza; R D Meyer; D F Busch
Journal:  Am J Clin Pathol       Date:  1978-07       Impact factor: 2.493

2.  Antimicrobial synergism--an elusive concept.

Authors:  R C Moellering
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

3.  Experimental bacterial endocarditis. I. Colonization of a sterile vegetation.

Authors:  D T Durack; P B Beeson
Journal:  Br J Exp Pathol       Date:  1972-02

4.  Group G streptococcal arthritis.

Authors:  M M Nakata; J H Silvers; W L George
Journal:  Arch Intern Med       Date:  1983-07

5.  Septic arthritis due to group G streptococcus.

Authors:  N K Fujita; K Lam; A S Bayer
Journal:  JAMA       Date:  1982-02-12       Impact factor: 56.272

6.  Activity of nine antimicrobial agents against Lancefield group C and group G streptococci.

Authors:  K V Rolston; J L LeFrock; R F Schell
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

7.  In vitro susceptibility of group G streptococci to ten antimicrobial agents with broad gram-positive spectra.

Authors:  A S Bayer; K Lam
Journal:  Clin Ther       Date:  1983       Impact factor: 3.393

8.  Serious infections due to group G streptoccocci. Report of 15 cases with in vitro-in vivo correlations.

Authors:  K Lam; A S Bayer
Journal:  Am J Med       Date:  1983-10       Impact factor: 4.965

9.  Group G streptococcal arthritis.

Authors:  A N Lin; A Karasik; I E Salit; A G Fam
Journal:  J Rheumatol       Date:  1982 May-Jun       Impact factor: 4.666

10.  Studies on the pathophysiology and some host defense factors in staphylococcal arthritis in the rabbit and on the relationship of aseptic inflammation to infection rate.

Authors:  D A Nagel; J A Albright; J W Hollingsworth
Journal:  Yale J Biol Med       Date:  1966-10
  10 in total
  11 in total

1.  High-level aminoglycoside resistance in the beta-hemolytic group G Streptococcus isolate BM2721.

Authors:  M Galimand; T Lambert; G Gerbaud; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

Review 2.  Streptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection.

Authors:  S Rantala
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-29       Impact factor: 3.267

3.  Infective endocarditis due to Streptococcus dysgalactiae: clinical presentation and microbiological features.

Authors:  Anna Bläckberg; Bo Nilson; Volkan Özenci; Lars Olaison; Magnus Rasmussen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-08       Impact factor: 3.267

4.  Susceptibility of group B and group G streptococci to newer antimicrobial agents.

Authors:  K V Rolston
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

Review 5.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

6.  Antibiotic susceptibilities of group C and group G streptococci isolated from patients with invasive infections: evidence of vancomycin tolerance among group G serotypes.

Authors:  T Zaoutis; B Schneider; L Steele Moore; J D Klein
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

7.  Clinical features and antimicrobial therapy of infections caused by group G streptococci.

Authors:  K V Rolston; P H Chandrasekar; J L LeFrock
Journal:  Infection       Date:  1985 Sep-Oct       Impact factor: 3.553

8.  Penicillin-induced effects on streptomycin uptake and early bactericidal activity differ in viridans group and enterococcal streptococci.

Authors:  M H Miller; M A el-Sokkary; S A Feinstein; F D Lowy
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

9.  Infective endocarditis and infected aneurysm caused by Streptococcus dysgalactiae subsp. equisimilis: a case report.

Authors:  Naoki Watanabe; Shuji Bandoh; Tomoya Ishii; Kiyoshi Negayama; Norimitsu Kadowaki; Kyoko Yokota
Journal:  Clin Case Rep       Date:  2017-01-24

10.  AZDAST the new horizon in antimicrobial synergism detection.

Authors:  Navid Ziaei-Darounkalaei; Mehrdad Ameri; Taghi Zahraei-Salehi; Omid Ziaei-Darounkalaei; Tahereh Mohajer-Tabrizi; Lotfollah Bornaei
Journal:  MethodsX       Date:  2016-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.